Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Wardelmann

Showing results (1-10 of 248) with videos related to

Pageof 25
Sort By:
Pathologie (Heidelberg, Germany)|October 12, 2022
[Ekkehard Grundmann : 28 September 1921-25 March 2022]Eva Wardelmann
Der Pathologe|April 29, 2021
[New WHO classifications and digital learning]Eva Wardelmann
Der Pathologe|April 29, 2022
[Connective (tissue) pathology: What brings us together!]Eva Wardelmann
Pathologie (Heidelberg, Germany)|November 15, 2022
[Opening speech by the conference president]Eva Wardelmann
Der Pathologe|April 6, 2021
[New in the current WHO classification (2020) for soft tissue sarcomas]Eva Wardelmann, Wolfgang Hartmann
The Lancet. Oncology|October 4, 2019
High Z nanoparticles and radiotherapy: a critical view - Authors' replySylvie Bonvalot, Eva Wardelmann, Cécile Le Péchoux
Onkologie|January 31, 2012
Targeted therapy of soft tissue sarcomasEva Wardelmann, Jens M Chemnitz, Clemens-Martin Wendtner
Expert Review of Anticancer Therapy|May 16, 2012
Gastrointestinal stromal tumors: evolving role of the multidisciplinary team approach in managementPeter Reichardt, Carlo Morosi, Eva Wardelmann, et al.
Translational Gastroenterology and Hepatology|March 20, 2018
SWOG study shows significant long-term overall survival for advanced gastrointestinal stromal tumor patients with imatinib treatmentMarcel Trautmann, Sebastian Huss, Wolfgang Hartmann, et al.
Biomed Research International|June 25, 2015
Lack of Association between Membrane-Type 1 Matrix Metalloproteinase Expression and Clinically Relevant Molecular or Morphologic Tumor Characteristics at the Leading Edge of Invasive Colorectal CarcinomaAnnette Arndt, Klaus Kraft, Eva Wardelmann, et al.
Pageof 25

Showing results (1-10 of 248) with videos related to

Sort By:
Pageof 25
Pathologie (Heidelberg, Germany)|October 12, 2022
[Ekkehard Grundmann : 28 September 1921-25 March 2022]Eva Wardelmann
Der Pathologe|April 29, 2021
[New WHO classifications and digital learning]Eva Wardelmann
Der Pathologe|April 29, 2022
[Connective (tissue) pathology: What brings us together!]Eva Wardelmann
Pathologie (Heidelberg, Germany)|November 15, 2022
[Opening speech by the conference president]Eva Wardelmann
Der Pathologe|April 6, 2021
[New in the current WHO classification (2020) for soft tissue sarcomas]Eva Wardelmann, Wolfgang Hartmann
The Lancet. Oncology|October 4, 2019
High Z nanoparticles and radiotherapy: a critical view - Authors' replySylvie Bonvalot, Eva Wardelmann, Cécile Le Péchoux
Onkologie|January 31, 2012
Targeted therapy of soft tissue sarcomasEva Wardelmann, Jens M Chemnitz, Clemens-Martin Wendtner
Expert Review of Anticancer Therapy|May 16, 2012
Gastrointestinal stromal tumors: evolving role of the multidisciplinary team approach in managementPeter Reichardt, Carlo Morosi, Eva Wardelmann, et al.
Translational Gastroenterology and Hepatology|March 20, 2018
SWOG study shows significant long-term overall survival for advanced gastrointestinal stromal tumor patients with imatinib treatmentMarcel Trautmann, Sebastian Huss, Wolfgang Hartmann, et al.
Biomed Research International|June 25, 2015
Lack of Association between Membrane-Type 1 Matrix Metalloproteinase Expression and Clinically Relevant Molecular or Morphologic Tumor Characteristics at the Leading Edge of Invasive Colorectal CarcinomaAnnette Arndt, Klaus Kraft, Eva Wardelmann, et al.
Pageof 25